Wealth Preservation Advisors’s Edwards Lifesciences EW Stock Holding History

Wealth Preservation Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.84K	Buy	+23	New	+$1.9K	﹤0.01%	604

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Wealth Preservation Advisors's EW Position: Q1 2026 in Review

Wealth Preservation Advisors opened a new position in Edwards Lifesciences (EW) in Q1 2026: 23 shares worth $1.84K. The stake represents ﹤0.01% of the portfolio and ranks #604 among its holdings.

1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Wealth Preservation Advisors held 23 shares of Edwards Lifesciences worth $1.84K as of Q1 2026.
Edwards Lifesciences was a new Wealth Preservation Advisors position in Q1 2026.
Edwards Lifesciences made up ﹤0.01% of Wealth Preservation Advisors's portfolio in Q1 2026, its #604 holding.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Wealth Preservation Advisors's 13F filing for Q1 2026, filed 15 May 2026.